Wisit Cheungpasitporn MD FACP | FASN | FAST

Prof. @MayoClinic | Leading AI Innovation in Nephrology. Physician-Scientist transforming Kidney Care with Generative AI & Machine Learning. #MedEd #Nephrology

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

Thank you 🙏🏻 @ASNKidney and Champion Dr. Navdeep Tangri for launching the Partnership for Responsible AI in Kidney Health.
I am honored to be part of this initiative and look forward to contributing to the advancement of AI in nephrology. Together, we can make a significant impact on patient care, research, and innovation. #AI #KidneyHealth #Nephrology 🙏🏻🙂

[Abdelhamed Hamdy @Abdelhamed012]

Contrast-Associated Acute Kidney Injury: Comprehensive Review of Risk Factors, Pathophysiology, Definition and Management - Mayo Clinic Proceedings https://t.co/4n07t6RvzY

[Fernando Fervenza @fervenzaf]

Dr. Glassock presenting on treatment of primary podocytopaties at the Mayo GNs Course.

[Krista Lentine, MD,PhD | FASN | FAST @KristaLentine]

📣 New publication in @FrontiersIn - Nephrology 📖

We are pleased to share our new work:
'Beyond the test: patient-reported concerns and worries regarding kidney conditions and #APOL1 genetic testing among Black patients'

🧬Among 200 Black adults in the #StLouis APOL1 cohort study with completed 3-month follow-up, 17.5% had an APOL1 high-risk genotype (2 risk variants).
🔵 At baseline, concerns about kidney conditions were substantial, with 39% of participants reporting being extremely concerned. At 3 months, concern remained unchanged in 45%, decreased in 36%, and increased in 19%.
🔵 APOL1 high-risk genotypes were more common among participants whose kidney concerns increased compared with those whose concerns decreased (29% vs 11%; P = 0.02).
🔵 Worry specifically related to having an APOL1 high-risk genotype declined from 14% at baseline to 8% at 3 months.

These findings highlight the importance of understanding the patient experience alongside genetic risk and of developing patient-centered education, communication, and counseling around APOL1 genetic testing.

🤝🏽 We are deeply grateful to the participants who shared their experiences and made this work possible, ➕ to our dedicated co-authors: @renginels | Bryan Clair | @AlizaAnwarMemo1 | John Edwards | @KanaHelloKidney | @Barisafsar75 | Mark Schnitzler | Huiling Xiao | Amber Carriker | Fadee Abu Al Rub | Chi-yuan Hsu | Anthony Muiru | Barry Freedman | Marie Philipneri | @yasar_caliskan

🌟 We also thank the St. Louis APOL1 Study Collaborators for their partnership: Orhun Aydin | Ezequiel Bellorin Font | @AvaDelonai6124 | @HoujeijNourhan | Kevin Lee | @nephrom | @drrushdafaruk | Marilyn Maxwell | Mowaffaq Said | @Farzana_HoqueMD | Amy Mosman | Anne Buganski | Mary Lesko | Kenan Li| Enbal Shacham | @MaiVoMD

We are especially grateful to Mid-America Transplant for invaluable support ➕commitment to our shared #StLouis kidney #community. 💙💚

🏥 @SSMHealthSTL | @SSMHealth | @slusom | #MidAmericaTransplant | @UCSF | @WakeForest

We look forward to continuing to connect with our community around kidney health, transplantation, research, and education at upcoming events—including the Celebrate Life Walk, PKD Walk and ASN Kidney Week

💫 #Nephrology #APOL1 #KidneyDisease #GeneticTesting #Genomics #PatientCentered #KidneyHealth #ClinicalResearch 🧬

📖 Read the full open-access article and learn more about what patients report about kidney health and APOL1 genetic testing: https://t.co/lLiGdK43bl

[Leticia Rolon @LeticiaRolonMD]

Back to the podium is Dr. @fervenzaf sharing Advances in Management of Patients with MN. We’ve come a long way with antigen discovery and the prospect of antigen-driven management and now with new therapies in the horizon…@MayoClinicNeph Selected Topics in GN

[Fernando Fervenza @fervenzaf]

Professor Roccatello giving a State of the Art lecture on Cryoglobulins.

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

📚🙏🏻 Thank you to American Society of Nephrology (ASN) In The Loop for highlighting our article this morning! 😊

I am thrilled to see our newly published Perspective, now available ahead of print in Kidney360, featured by the American Society of Nephrology, ASN in the Loop. 🔁

“Artificial Intelligence in Nephrology Practice: Practical Pathways to Improve Efficiency”
In this piece, we explore practical opportunities to integrate AI into everyday nephrology workflows—supporting care before, during, and after the patient visit. 
Our focus highlights how we can:
🔹 Improve Efficiency: Utilizing workflow AI to assemble information, draft documentation, and streamline routine clinical tasks to significantly reduce administrative burden.
🔹 Support Clinicians: Designing practical pathways that serve as a force multiplier for kidney care professionals.
🔹 Maintain Human Oversight: Ensuring that AI implementation remains responsible, with clinicians firmly at the center of verification and decision-making. 
As the feature notes, our next priority as a field must be rigorous multicenter studies to evaluate the effectiveness, safety, workload impact, patient experience, and cost of these AI-enabled workflows. 
A sincere thank you to my fantastic co-authors, Dr. Noppawit Aiumtrakul and Dr. Charat Thongprayoon, for this great collaboration! 🙏🏻 Thank you as well to @asnpublications for sharing this piece.
@NoppawitMD @MayoClinicNeph
🔓 Read the full article here:
🔗 https://t.co/znrCug2cHg
(DOI: 10.34067/KID.0000001424)
Wisit Cheungpasitporn, MD, FACP, FASN, FAST
Professor of Medicine, Division of Nephrology and Hypertension
AI Course Director, Mayo Clinic Alix School of Medicine
Mayo Clinic, Minnesota
#ArtificialIntelligence #Nephrology #Kidney360 #DigitalHealth #ClinicalAI #MayoClinic

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

🇸🇬 🙂🙏🏻 Grateful to the Society of Transplantation (Singapore) and Dr. Matthew D’Costa for the wonderful invitation to speak at the SOT Annual Scientific Meeting 2026! 🙏🏻 

It was an absolute pleasure to deliver my plenary, “AI in Transplantation — From Promise to Practice,” and discuss how artificial intelligence, machine learning, and advanced molecular diagnostics are actively reshaping the landscape of kidney transplantation. 

During the session, we explored:
🔹 Complementary Diagnostic Modalities: Understanding what each test measures—how blood-based dd-cfDNA quantifies cell death and active graft injury, while tissue-based MMDx reads living graft cells to reveal active biological mechanisms.
🔹 Machine Learning in Biopsy Assessment: How MMDx couples whole-genome microarrays with machine learning reference sets to output objective probability scores for TCMR, ABMR, acute injury, and irreversible fibrosis alongside Banff classification.
🔹 The Multimodal Horizon: Fusing molecular diagnostics, longitudinal biomarkers, digital pathology, and clinical data to power AI-assisted surveillance, predictive decision support, and truly personalized post-transplant care. 
Thank you to the organizers, faculty, and participants for the warm welcome, wonderful attendance, and thoughtful questions during our discussion. It is inspiring to see such strong collective momentum toward translating digital health and precision diagnostics into safer, more effective care for transplant recipients! 🤝🩺
Wisit Cheungpasitporn, MD, FACP, FASN, FAST @MayoClinicNeph
Professor of Medicine, Division of Nephrology and Hypertension
AI Course Director, Mayo Clinic Alix School of Medicine
Mayo Clinic, Minnesota 
#SOT2026 #Transplantation #KidneyTransplant #ArtificialIntelligence #AIinHealthcare #PrecisionMedicine #DigitalHealth #Nephrology #MachineLearning #Singapore #MayoClinic

[Hatem Amer, MD, FASN, FAST @h4amer]

Superb lectures and interactive discussion. Cases were very educational.

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

🇸🇬 🙂🙏🏻 Grateful to the Society of Transplantation (Singapore) and Dr. Matthew D’Costa for the wonderful invitation to speak at the SOT Annual Scientific Meeting 2026! 🙏🏻 

It was an absolute pleasure to deliver my plenary, “AI in Transplantation — From Promise to Practice,” and discuss how artificial intelligence, machine learning, and advanced molecular diagnostics are actively reshaping the landscape of kidney transplantation. 

During the session, we explored:
🔹 Complementary Diagnostic Modalities: Understanding what each test measures—how blood-based dd-cfDNA quantifies cell death and active graft injury, while tissue-based MMDx reads living graft cells to reveal active biological mechanisms.
🔹 Machine Learning in Biopsy Assessment: How MMDx couples whole-genome microarrays with machine learning reference sets to output objective probability scores for TCMR, ABMR, acute injury, and irreversible fibrosis alongside Banff classification.
🔹 The Multimodal Horizon: Fusing molecular diagnostics, longitudinal biomarkers, digital pathology, and clinical data to power AI-assisted surveillance, predictive decision support, and truly personalized post-transplant care. 
Thank you to the organizers, faculty, and participants for the warm welcome, wonderful attendance, and thoughtful questions during our discussion. It is inspiring to see such strong collective momentum toward translating digital health and precision diagnostics into safer, more effective care for transplant recipients! 🤝🩺
Wisit Cheungpasitporn, MD, FACP, FASN, FAST @MayoClinicNeph
Professor of Medicine, Division of Nephrology and Hypertension
AI Course Director, Mayo Clinic Alix School of Medicine
Mayo Clinic, Minnesota 
#SOT2026 #Transplantation #KidneyTransplant #ArtificialIntelligence #AIinHealthcare #PrecisionMedicine #DigitalHealth #Nephrology #MachineLearning #Singapore #MayoClinic

[Sandra Herrmann MD, FASN @HerrmannMd]

@onconephsociety @onconeph @rc_oncneph @SheronLatcha @anuja_java @ShrutiGkidney @hhashmi87 @ZiolkowskiSusan @nymurakami @virginieroyal @PaulHannaMD @gabriellecote @itunuowoyemi @kdjhaveri https://t.co/wKH69JiY3p

[Leticia Rolon @LeticiaRolonMD]

The inaugural @MayoClinicNeph Glomerular Diseases & Kidney Pathology course is off to an exciting start! With over 1500 patients in our GN program and >500 new glomerular consults per year, as well as >9000 kidney biopsies read by our kidney pathology colleagues per year…

[Fernando Fervenza @fervenzaf]

First GN course going on now! 😀

[Leticia Rolon @LeticiaRolonMD]

Dr. @fervenzaf reminding us why we need to keep an eye on the source of inflammation in LN! Focusing on proteinuria may be misleading. Redefining “Endpoints in Lupus Nephritis” #Dontbiopsylava Better yet, monitor the immunologic activity to guide your management @MayoClinicNeph

[Leticia Rolon @LeticiaRolonMD]

Dr. @LadanZand leading a panel of experts @fervenzaf, @poyanmehr, & @GlassockJ through a complex series of cases in IgA nephropathy. Thought-provoking discussion on the when, who, what of immunosuppression v. conservative management! @MayoClinicNeph

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

@josearriolam @ASNKidney360 @mariehogan_md Congratulations 🎉 Great work!!😊

[Jose Arriola-Montenegro @josearriolam]

New in Kidney360 @ASNKidney360 : “Nutcracker Syndrome: The Nephrologist’s Perspective.” 🔥🔥👏🏽👏🏽

Deeply grateful to Drs. Marie Hogan @mariehogan_md , Wisit Cheungpasitporn @wisit661 , Thom Rooke, and Heraldur Bjarnason for their guidance, expertise, and collaboration across Nephrology and Hypertension, Cardiovascular Medicine, and Radiology, Vascular and Endovascular Surgery at Mayo Clinic. @MayoClinic @MayoClinicNeph @MayoClinicCV @MayoRadiology @MayoVascSurgery

We highlight a patient-centered, multidisciplinary approach to diagnosis, individualized treatment, chronic pain, and longitudinal care—emphasizing the nephrologist’s role in guiding patients through a complex, often misunderstood condition.

https://t.co/5v95sOmfeY

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

📚🙏🏻 Thank you to American Society of Nephrology (ASN) In The Loop for highlighting our article this morning! 😊

I am thrilled to see our newly published Perspective, now available ahead of print in Kidney360, featured by the American Society of Nephrology, ASN in the Loop. 🔁

“Artificial Intelligence in Nephrology Practice: Practical Pathways to Improve Efficiency”
In this piece, we explore practical opportunities to integrate AI into everyday nephrology workflows—supporting care before, during, and after the patient visit. 
Our focus highlights how we can:
🔹 Improve Efficiency: Utilizing workflow AI to assemble information, draft documentation, and streamline routine clinical tasks to significantly reduce administrative burden.
🔹 Support Clinicians: Designing practical pathways that serve as a force multiplier for kidney care professionals.
🔹 Maintain Human Oversight: Ensuring that AI implementation remains responsible, with clinicians firmly at the center of verification and decision-making. 
As the feature notes, our next priority as a field must be rigorous multicenter studies to evaluate the effectiveness, safety, workload impact, patient experience, and cost of these AI-enabled workflows. 
A sincere thank you to my fantastic co-authors, Dr. Noppawit Aiumtrakul and Dr. Charat Thongprayoon, for this great collaboration! 🙏🏻 Thank you as well to @asnpublications for sharing this piece.
@NoppawitMD @MayoClinicNeph
🔓 Read the full article here:
🔗 https://t.co/znrCug2cHg
(DOI: 10.34067/KID.0000001424)
Wisit Cheungpasitporn, MD, FACP, FASN, FAST
Professor of Medicine, Division of Nephrology and Hypertension
AI Course Director, Mayo Clinic Alix School of Medicine
Mayo Clinic, Minnesota
#ArtificialIntelligence #Nephrology #Kidney360 #DigitalHealth #ClinicalAI #MayoClinic

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

😊🙏🏻Looking forward to joining the Society of Transplantation Singapore (SOT) Annual Scientific Meeting 2026 this Saturday! 🇸🇬 
I am incredibly honored to deliver the keynote plenary:
“AI in Transplantation — From Promise to Practice” 
During our session, we will explore where AI is already beginning to influence transplantation, including:
🔹 Risk Stratification & Outcomes: Utilizing predictive modeling to improve patient care trajectories
🔹 Advanced Diagnostics: The integration of digital pathology, molecular diagnostics, and biomarkers
🔹 Decision Support: Leveraging multimodal data integration to empower clinicians and support precision medicine 
Crucially, we will also discuss what is still needed to move from promising algorithms toward reliable, clinically useful systems that firmly preserve human oversight and ensure patient safety. I look forward to learning from colleagues across the transplant community and discussing how we can translate these advances into safer, more effective care.
A sincere thank you to the Society of Transplantation Singapore (SOT) and Dr. Matthew D'Costa for the invitation and the opportunity to contribute to this important conversation! 🙏🏻 
📅 Date: Saturday, October 3, 2026
📍 Location: National Heart Centre Singapore 
Wisit Cheungpasitporn, MD, FACP, FASN, FAST @MayoClinicNeph
Professor of Medicine, Division of Nephrology and Hypertension
AI Course Director, Mayo Clinic Alix School of Medicine
Mayo Clinic, Minnesota 
#Transplantation #ArtificialIntelligence #AIinHealthcare #KidneyTransplant #DigitalHealth #PrecisionMedicine #TransplantMedicine #MachineLearning #Nephrology #SOTASM2026 #MayoClinic

[Nikhil Shah MBBS DNB(IM, Neph)🇨🇦 @dr_nikhilshah]

@PD_Perls @NephroShah
Dear Jeff, it was a pleasure and honor to work with you and learn from you. Thank you for your extraordinary guidance and mentorship. Very grateful 🙏.

Dear Ankur, welcome, I look forward to working with you and take @PDI_Journal to new heights. @ISPD1 #ISPD26

[Mayo Clinic Nephrology @MayoClinicNeph]

Dr. Andrew Rule from @MayoClinicNeph delivers a great keynote regarding AI and Kidney Stone research at 15th International Symposium on Urolithiasis
@AndrewRuleMD